BRPI0506279A - composição sinergìstica de antihelmìnticos e endectocidas - Google Patents

composição sinergìstica de antihelmìnticos e endectocidas

Info

Publication number
BRPI0506279A
BRPI0506279A BRPI0506279-9A BRPI0506279A BRPI0506279A BR PI0506279 A BRPI0506279 A BR PI0506279A BR PI0506279 A BRPI0506279 A BR PI0506279A BR PI0506279 A BRPI0506279 A BR PI0506279A
Authority
BR
Brazil
Prior art keywords
composition
endectocides
anthelmintics
synergistically
levemisol
Prior art date
Application number
BRPI0506279-9A
Other languages
English (en)
Inventor
Dolivar Coracci Neto
Nelson Henriques Fernandes Jr
Ricardo Da Silva Sercheli
Original Assignee
Ouro Fino Participacoes E Empr
Npa Nucleo De Pesquisas Aplic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ouro Fino Participacoes E Empr, Npa Nucleo De Pesquisas Aplic filed Critical Ouro Fino Participacoes E Empr
Priority to BRPI0506279-9A priority Critical patent/BRPI0506279B1/pt
Priority to PCT/BR2006/000282 priority patent/WO2007068073A2/en
Priority to US12/097,683 priority patent/US8227427B2/en
Priority to NZ569595A priority patent/NZ569595A/en
Priority to MX2008007773A priority patent/MX2008007773A/es
Priority to EP06817635.3A priority patent/EP1968585B1/en
Priority to AU2006324315A priority patent/AU2006324315B8/en
Publication of BRPI0506279A publication Critical patent/BRPI0506279A/pt
Priority to NI200800167A priority patent/NI200800167A/es
Priority to ZA200806165A priority patent/ZA200806165B/xx
Publication of BRPI0506279B1 publication Critical patent/BRPI0506279B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/06—Phenols the aromatic ring being substituted by nitro groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

COMPOSIçãO SINERGìSTICA DE ANTIHELMìNTICOS E ENDECTOCIDAS, nada mais é do que a composição veterinária para o controle de helmintos em bovinos, suínos, caprinos, eqüídeos, ovinos, caninos e felinos, esta invenção está relacionada à associação de sais orgânicos de levamisol, mais especificamente o disofenolato de levamisol e o nitroxinato de levamisol, com avermectinas e milbemicinas em formulações veterinárias e seu uso no tratamento de helmintíases em mamíferos.
BRPI0506279-9A 2005-12-16 2005-12-16 Composição sinergística de antihelmínticos e endectocidas BRPI0506279B1 (pt)

Priority Applications (9)

Application Number Priority Date Filing Date Title
BRPI0506279-9A BRPI0506279B1 (pt) 2005-12-16 2005-12-16 Composição sinergística de antihelmínticos e endectocidas
PCT/BR2006/000282 WO2007068073A2 (en) 2005-12-16 2006-12-18 Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectine and/or milbemycine
US12/097,683 US8227427B2 (en) 2005-12-16 2006-12-18 Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectin and/or milbemycin
NZ569595A NZ569595A (en) 2005-12-16 2006-12-18 Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectine and/or milbemycine
MX2008007773A MX2008007773A (es) 2005-12-16 2006-12-18 Composicion veterinaria que comprende una sal organica de levamisol en combinacion con por lo menos una avermectina y/o milbemicina.
EP06817635.3A EP1968585B1 (en) 2005-12-16 2006-12-18 Veterinarian composition for use as fasciolicide in animals
AU2006324315A AU2006324315B8 (en) 2005-12-16 2006-12-18 Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectine and/or milbemycine
NI200800167A NI200800167A (es) 2005-12-16 2008-06-16 Composición veterinaria compuesta por sal orgánica de levamisol combinada con por lo menos una avermectina y/o milbemicina.
ZA200806165A ZA200806165B (en) 2005-12-16 2008-07-15 Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectine and/or milbemycine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0506279-9A BRPI0506279B1 (pt) 2005-12-16 2005-12-16 Composição sinergística de antihelmínticos e endectocidas

Publications (2)

Publication Number Publication Date
BRPI0506279A true BRPI0506279A (pt) 2007-10-02
BRPI0506279B1 BRPI0506279B1 (pt) 2018-01-09

Family

ID=38163265

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0506279-9A BRPI0506279B1 (pt) 2005-12-16 2005-12-16 Composição sinergística de antihelmínticos e endectocidas

Country Status (9)

Country Link
US (1) US8227427B2 (pt)
EP (1) EP1968585B1 (pt)
AU (1) AU2006324315B8 (pt)
BR (1) BRPI0506279B1 (pt)
MX (1) MX2008007773A (pt)
NI (1) NI200800167A (pt)
NZ (1) NZ569595A (pt)
WO (1) WO2007068073A2 (pt)
ZA (1) ZA200806165B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011054068A1 (pt) 2009-11-05 2011-05-12 Ouro Fino Participações E Empreendimentos S/A Associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2568980B1 (en) 2010-05-12 2015-11-11 Merial, Inc. Injectable parasiticidal formulations of levamisole and macrocyclic lactones
NZ612185A (en) 2010-12-07 2015-10-30 Merial Inc Topical combination formulations of macrocyclic lactones with synthetic pyrethroids
US9198430B2 (en) 2011-06-23 2015-12-01 Bayer New Zealand Limited Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation
CN102614173A (zh) * 2012-03-07 2012-08-01 西北农林科技大学 一种复方美贝霉素肟纳米乳抗寄生虫药物及其制备方法
BR102013031277B1 (pt) 2013-12-05 2018-10-02 Ouro Fino Participacoes E Empreendimentos S A processo para preparar uma suspensão anti-helmíntica e suspensão anti-helmíntica injetável

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ202422A (en) * 1981-11-25 1985-02-28 Ici Australia Ltd D, l-and l-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazolium 4-cyano-2-iodo-6-nitrophenoxide and veterinary compositions
ZA842571B (en) * 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
GB8331037D0 (en) 1983-11-21 1983-12-29 May & Baker Ltd Compositions of matter
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
NZ248486A (en) 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
DE60025198D1 (de) * 1999-06-04 2006-02-02 Nufarm Ltd Stabile biozidale zusammensetzung
GB2386067A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
NZ520295A (en) 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
TWI366442B (en) * 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
BRPI0505716B1 (pt) 2005-12-15 2016-12-20 Npa Núcleo De Pesquisas Aplic S Ltda sal orgânico de levamisol, processo de preparação do mesmo, composição farmacêutica e seu uso no combate de helmintiases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011054068A1 (pt) 2009-11-05 2011-05-12 Ouro Fino Participações E Empreendimentos S/A Associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais

Also Published As

Publication number Publication date
AU2006324315B8 (en) 2013-02-21
WO2007068073A3 (en) 2007-08-16
AU2006324315A1 (en) 2007-06-21
NZ569595A (en) 2010-08-27
WO2007068073A2 (en) 2007-06-21
MX2008007773A (es) 2008-12-09
EP1968585A2 (en) 2008-09-17
AU2006324315A8 (en) 2013-02-21
NI200800167A (es) 2011-12-14
EP1968585A4 (en) 2009-11-18
AU2006324315B2 (en) 2012-10-25
US20090075918A1 (en) 2009-03-19
ZA200806165B (en) 2010-03-31
US8227427B2 (en) 2012-07-24
EP1968585B1 (en) 2013-12-18
BRPI0506279B1 (pt) 2018-01-09

Similar Documents

Publication Publication Date Title
BRPI0506279A (pt) composição sinergìstica de antihelmìnticos e endectocidas
BR112014019262A8 (pt) Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas
BRPI0519135A2 (pt) macrolÍdeos
BRPI0510449A (pt) uso de formulações de meloxicam em medicina veterinária
SV2011003842A (es) Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol
BR112012015960A2 (pt) Composições incluindo piruvato para animais de companhia e métodos de uso destas.
BR112012025203A2 (pt) composições parasiticidas compreendendo múltiplos agentes ativos, método e usos das mesmas
UY28757A1 (es) Compuestos de pirazolina substituidos, su preparación y su uso como medicamentos
BRPI0922041A8 (pt) Formulações compreendendo ceftiofur e cetoprofeno ou cetiofur e álcool benzílico.
BRPI0807790A2 (pt) Composição de ração para animal de estimação, e, uso da mesma
BR112013016021A2 (pt) métodos e composições adequadas para gerenciar glicemia em animais
BR122019020753B8 (pt) uso de formulações que compreendem toltrazuril, ou seus sais fisiologicamente aceitáveis, e um composto de ferro (iii) dextrana
CL2008000401A1 (es) Metodo para prevenir o tratar infestacion de ectoparasito en un animal durante un periodo mayor de 6 semanas que comprende administrar composicion ectoparacitida en dosis 1,5 a 5 veces la cantidad que se aplica convencionalmente; composicion que comp
BRPI0911031B8 (pt) compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes
PE20070521A1 (es) 7-[2-[4-(6-FLUORO-3-METIL-1,2-BENCISOXAZOL-5-IL)-1-PIPERAZINIL]ETIL]-2-(1-PROPINIL)-7H-PIRAZOL-[4,3-E]-[1,2,4]-TRIAZOL-[1,5-C]-PIRIMIDIN-5-AMINA COMO ANTAGONISTA DEL RECEPTOR DE ADENOSINA A2a
BR112012010689B8 (pt) mistura antifúngica com organismo fúngico
BRPI0919231A2 (pt) agonista de receptor de neuropeptídeo-2, composição farmacêutica que o compreende, seu uso e método para o tratamento ou profilaxia de enfermidades
BR112013020802A2 (pt) métodos e composições para tratar, reduzir ou impedir dano ao sistema nervoso de animais
BRPI0912112B8 (pt) composição farmacêutica compreendendo composto tendo atividade antagonística em receptor de adenosina a2a útil em suprimir tolerância analgésica
UY33003A (es) Asociaciones farmacéuticas, composiciones farmacéuticas, medicamento y método para el tratamiento de animales
BRPI0700969A (pt) composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
BR112022004036A2 (pt) Comprimido mastigável palatável
UY30706A1 (es) Diaril, dipiridinil y arilpiridinil derivados y usos de los mismos
BRPI0813159A2 (pt) Composição parasiticida veterinária, método para o tratamento ou controle de uma infecção ou infestação parasiticidas em um animal homeotérico, e, uso de uma composição
BR112015006282A2 (pt) composições e métodos de uso de um composto para controle de inapetência

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT. CL. A01N 45/00 , A01N 43/90, A61K 31/365, A61K 31/429, A61P 33/10.

Ipc: A61K 31/365 (2006.01), A61K 31/429 (2006.01), A61P

B25A Requested transfer of rights approved

Owner name: NPA - NUCLEO DE PESQUISAS APLICADAS LTDA (BR/SP) ,

B65X Notification of requirement for priority examination of patent application
B65Y Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117)
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B25C Requirement related to requested transfer of rights

Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 870210021930 DE 08/03/2021, E NECESSARIO APRESENTAR DOCUMENTO QUE COMPROVE QUE OS REPRESENTANTES DA EMPRESA CEDENTE TEM PODERES PARA REALIZAR TAL ATO. ALEM DISSO, E PRECISO APRESENTAR A GUIA DE CUMPRIMENTO DE EXIGENCIA.

B25A Requested transfer of rights approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2701 DE 11-10-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.